A
TXMD icon

AJOVista’s TherapeuticsMD TXMD Stock Holding History

AJOVista’s Portfolio TXMD Stock Details TXMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-2,151
Closed -$4.84K – 395
2023
Q4 		$4.84K Buy
+2,151
New +$5.19K 0.01% 454

Other funds holding TXMD

RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
CC
Clearline Capital New York $1.93B AUM 38.13% 1-Year Est. Return
TC
Tejara Capital London, United Kingdom $303M AUM 5.43% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AJOVista's TXMD Position: Q1 2024 in Review

AJOVista sold out of TherapeuticsMD (TXMD) in Q1 2024, closing a stake of 2,151 shares — an estimated $4.84K sold.

AJOVista first reported a position in TXMD in Q4 2023 and held it in 1 quarter. The position peaked at $4.84K in Q4 2023. 43 funds tracked by Wall St. Rank hold TXMD as of Q1 2024.

  • AJOVista reported no remaining TherapeuticsMD position as of Q1 2024 after selling out during the quarter.
  • AJOVista sold 2,151 TherapeuticsMD shares in Q1 2024, an estimated $4.84K.
  • AJOVista first reported a position in TherapeuticsMD in Q4 2023 and held it in 1 quarter.
  • AJOVista's TherapeuticsMD position peaked at $4.84K in Q4 2023.
  • 43 funds tracked by Wall St. Rank held TherapeuticsMD as of Q1 2024.

Based on AJOVista's 13F filing for Q1 2024, filed 10 May 2024.